Hepatocellular Carcinoma
(Hepatology. 2005;42:1208-29)
DEFINITION:
Hepatocellular carcinoma (HCC) or Hepatoma is a primary (as opposed to metastases) tumor of the liver
EPIDEMIOLOGY:
Mortality: 4th most common cause of world cancer deaths (400,000-1 million) annually; Incidence remains on the rise worldwide: 3 per 100,000
♂ > ♀ (2-6 times more men affected); Mean age at presentation is 50-60 years with most being older than 55
Approximately 80% of patients with HCC have cirrhosis
ETIOLOGIES:
Can be seen in any chronic liver disease, but most often seen with:
Chronic hepatitis C (probably the most common); Chronic Hepatitis B; Hemochromatosis; α1-AT; Alcoholic cirrhosis
Environmental toxin exposure (i.e. alflatoxin)
Cirrhosis of any cause!
PATHOPHYSIOLOGY:
▪ | Presenting forms: | Nodular: most common, multiple nodules of varying size scattered throughout liver |
Solitary: occurs in younger patients; large, solitary mass, often right lobe | ||
Diffuse: rare; difficult to detect on imaging; widespread infiltration of minute tumor foci |
Fibrolamellar carcinoma (represents 7% of HCC): occurs in young people (mean age 26), ♂ = ♀, seldom have history of prior liver disease
Usually presents with abdominal pain due to large mass, most often left lobe (75%); AFP is normal
Histology includes deeply eosinophilic malignant cells interspersed between laminated strands of collagen
Imaging studies show fibrous central scar from bleed/necrosis; MRI T2 demonstrates hypointense (don’t confuse with FNH)
Recognition is key as 50-80% are resectable at diagnosis; Liver transplant may be indication if not resectable
CLINICAL MANIFESTATIONS/PHYSICAL EXAM:
Usually have no symptoms or may be manifestations of chronic liver disease
Rare: abdominal pain, early satiety, weight loss, jaundice, paraneoplastic syndromes, fever
In previously compensated cirrhotics, the development of decompensation should raise suspicion of HCC!
Physical exam usually reflects the underlying liver disease:
Hepatomegaly/splenomegaly, ascites, jaundice; Less common: fever, palpable liver mass, hepatic bruit
LABORATORY STUDIES:
Alpha-Fetoprotein (AFP) in a patient with chronic liver disease should raise concern that HCC has developed
Levels >500 ng/ml (normal 10-20) in a high risk patient is generally accepted to be diagnostic and further workup not required
AFP is a glycoprotein normally produced during gestation via the fetal liver and yolk sac
Also elevated in pregnancy, tumors of gonadal origin, or in patients with acute/chronic liver disease without HCC
Limitations: usually normal in majority of patients with Fibrolamellar Carcinoma (as noted above is a variant of HCC) and 40% of small HCCs (<2 cm)Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree